Deals
Tetraphase Said to Explore Sale After Takeover Interest
This article is for subscribers only.
Tetraphase Pharmaceuticals Inc., a maker of antibiotics to treat serious infections, is exploring a sale after attracting interest from potential buyers, people familiar with the matter said.
The biotechnology company is working with advisers to explore its options, the people said, asking not to be identified because the deliberations are private. Tetraphase may attract interest from bidders including Actelion Ltd. and Roche Holding AG, the people said.